Tag Archives: intravenous

Intravenous infusion of exenatide does not reduce the risk of complications in patients after heart surgery

A large-scale clinical trial has shown that intravenous infusion of the glucagon-like peptide-1 (GLP-1) analogue exenatide during heart surgery involving bypass does not significantly reduce the risk of death, stroke, or organ failure. Scientists today presented this preliminary, groundbreaking science study at the American Heart Association 2024 Scientific Sessions. The meeting, taking place November 16-18, […]

Sustainable strategy reduces inappropriate intravenous apply by one third

The Amsterdam UMC study, conducted over five years and involving 1,100 patients, showed the strategy reduced inappropriate intravenous apply by one third, an effect that was maintained over the five-year period. It should also lead to a reduction in the number of related infections, which affect one in ten patients. The results were published today […]